Hanseatic Management Services’s Neurocrine Biosciences NBIX Stock Holding History

Hanseatic Management Services’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,559	Closed	-$545K	–	131
2022 Q4	$545K	Buy	+4,559	New	+$534K	1.38%	16
2020 Q1	–	Sell	-9,047	Closed	-$972K	–	247
2019 Q4	$972K	Buy	+9,047	New	+$947K	0.89%	32
2018 Q4	–	Sell	-10,507	Closed	-$1.29M	–	313
2018 Q3	$1.29M	Sell	10,507 -2,407	-19%	-$273K	1.2%	17
2018 Q2	$1.27M	Buy	12,914 +462	+4%	+$41.4K	1.09%	21
2018 Q1	$1.03M	Buy	12,452 +21	+0.2%	+$1.77K	0.99%	25
2017 Q4	$965K	Buy	+12,431	New	+$848K	0.97%	30
2016 Q1	–	Sell	-35,752	Closed	-$2.02M	–	289
2015 Q4	$2.02M	Sell	35,752 -147	-0.4%	-$7.47K	0.7%	51
2015 Q3	$1.43M	Buy	35,899 +17,563	+96%	+$849K	0.44%	88
2015 Q2	$876K	Buy	18,336 +4,716	+35%	+$200K	0.39%	96
2015 Q1	$541K	Buy	+13,620	New	+$487K	0.29%	96
2013 Q3	–	Sell	-3,778	Closed	-$51K	–	267
2013 Q2	$51K	Buy	+3,778	New	+$46.4K	0.03%	123

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hanseatic Management Services's NBIX Position: Q1 2023 in Review

Hanseatic Management Services sold out of Neurocrine Biosciences (NBIX) in Q1 2023, closing a stake of 4,559 shares — an estimated $545K sold.

Hanseatic Management Services first reported a position in NBIX in Q2 2013 and held it in 11 quarters. The position peaked at $2.02M in Q4 2015. 486 funds tracked by Wall St. Rank hold NBIX as of Q1 2023.

Hanseatic Management Services reported no remaining Neurocrine Biosciences position as of Q1 2023 after selling out during the quarter.
Hanseatic Management Services sold 4,559 Neurocrine Biosciences shares in Q1 2023, an estimated $545K.
Hanseatic Management Services first reported a position in Neurocrine Biosciences in Q2 2013 and held it in 11 quarters.
Hanseatic Management Services's Neurocrine Biosciences position peaked at $2.02M in Q4 2015.
486 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2023.

Based on Hanseatic Management Services's 13F filing for Q1 2023, filed 12 May 2023.